*By Christian Smith*
After an overdose earlier this week, Demi Lovato's life was reportedly saved by Narcan, a nasal administrator of naloxone that counteracts the effects of opioids. When administered quicklyーthrough either nasal mist or injectionーnaloxone can temporarily halt an overdose, allowing EMTs enough time to respond. The medication is available without a prescription in 49 states, and the generic version costs about $20 per dose.
But all merits aside, is the drug's accessibility enabling addicts to push their limits?
Dr. Roger Crystal, the lead inventor of Narcan and CEO of Opiant Pharmaceuticals, says there's little evidence to support that concern.
"Addiction like any kind of chronic disease is something you can control using better medication, but ultimately you can't cure," Crystal told Cheddar. "To think about an opioid addict behaving rationally and saying, 'well because I have access to Narcan I'll shoot more heroin, inject more heroin' there's no proof for that whatsoever."
Naloxone is considered some of the best ammunition on the front lines of America's growing opioid epidemic. A reported 2 million Americans have an addition to opioidsーand the number isn't going down. U.S. Surgeon General Jerome Adams [issued an advisory](https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html) in April urging anyoneーand their close family and friendsーwho uses painkillers, heroin, fentanyl, or other opioids to carry naloxone in case of an emergency.
Crystal isn't stopping at Narcan: he told Cheddar he's also developing a heroin vaccine, suggesting the inventor has lofty ambitions for the future of overdose prevention.
Although Crystal may be aware of lingering ethical concerns, he doesn't think they dwarf his mission. After all, Lovato has him to thank.
"Putting it in the hands of everyone and anyone is critical," Crystal said.
For more on this story, [click here](https://cheddar.com/videos/how-one-pharmaceutical-company-is-fighting-the-opioid-epidemic).
Cheddar's CannaBiz explores the latest trends, politics, and market opportunity in this space. Cheddar Anchor's Brad Smith, Hope King and Alyssa Julya Smith speak with legislators and start-up founders in this emerging market.
This Changes Things: Advice for the executives and leaders of tomorrow, brought to you by American Express OPEN. On Between Bells: The Bachelor finale and big changes at ESPN. With Popular Science, Us Weekly, and more.
His new Amazon bestseller, "The Longevity Diet," helps patients to live longer, healthier and more fulfilling lives by slowing aging, fighting disease and optimizing weight. Dr. Valter Longo sits down with Alyssa Julya Smith in Los Angeles to share some of his secrets to living a healthier life.
Marrying your cousin has long been considered taboo, but new research says that procreating with your cousins may not be as risky as previously thought. Popular Science's Eleanor Cummins breaks down the findings.
Sarah Lewin, associate editor at Space.com, breaks down SpaceX's landmark 50th Falcon 9 launch. The rocket took off early Tuesday morning, launching a communications satellite into orbit.
The Dow closes up more than 300 points as trade war fears subside. Amazon is looking to team up with banks to build a checking account-type product. There's also new speculation on where Amazon's HQ2 might be located. Apple reportedly releasing a cheaper MacBook Air. Former Trump campaign aide refuses to cooperated and the Mueller investigation.
Every three minutes, someone in the U.S. is diagnosed with blood cancer. These people often rely on bone marrow donations to survive, but getting a match can be difficult. To make registering easier, the non-profit DKMS has launched virtual bone marrow drives.
Dina Fine Maron, health & science editor at Scientific American, discusses the breakthrough that could help doctors diagnose mental illnesses. Stem cells have enabled researchers to see how lithium affects the brain.
Eric Harris, president and chief operating officer at Cheddar, joins us to talk about the company's participation in Cycle for Survival, an indoor charity cycling event raising money for rare cancers.
Snap is planning to release new versions of its hugely unpopular Spectacles. The Weinstein Co. lives to fight another day after a last-minute deal emerged Thursday night.
